JAMA internal medicine

The value of pharmacogenetic testing—reply.

JAMA internal medicine

Kazi DS, Hlatky MA

Shared decision-making: easy to evoke, challenging to implement.

JAMA internal medicine

Kuppermann M, Sawaya GF

The importance of postapproval data for dabigatran.

JAMA internal medicine

Redberg RF

A new program for sharing medical cost information.

JAMA internal medicine

Redberg RF

A new program for sharing medical cost information.

JAMA internal medicine

Redberg RF

The importance of postapproval data for dabigatran.

JAMA internal medicine

Redberg RF

Assessing the safety and effectiveness of devices after US Food and Drug Administration approval: FDA-mandated postapproval studies.

JAMA internal medicine

Reynolds IS, Rising JP, Coukell AJ, Paulson KH, Redberg RF

Timeliness of care in US emergency departments: an analysis of newly released metrics from the Centers for Medicare & Medicaid services.

JAMA internal medicine

Le ST, Hsia RY

Association between emergency department length of stay and rates of admission to inpatient and observation services.

JAMA internal medicine

Carrier E, Khaldun J, Hsia RY

Assessing the safety and effectiveness of devices after US Food and Drug Administration approval: FDA-mandated postapproval studies.

JAMA internal medicine

Reynolds IS, Rising JP, Coukell AJ, Paulson KH, Redberg RF

Pages